MAIT cells confer resistance to Lenvatinib plus anti-PD1 antibodies in hepatocellular carcinoma through TNF-TNFRSF1B pathway
Cheng Zhou, Bao‐Ye Sun, Pei‐Yun Zhou, Zhangfu Yang, Zhu-Tao Wang, Gao Liu, Wei Gan, Zheng Wang, Jian Zhou, Jia Fan, Yong Yi, Ning Ren, Shuang‐Jian Qiu
Topics & Concepts
LenvatinibMedicineAntibodyCancer researchHepatocellular carcinomaCD8Immune systemImmunologyOncologySorafenibImmune Cell Function and InteractionPhagocytosis and Immune RegulationCancer Immunotherapy and Biomarkers